Aromatase inhibitor “letrozole” versus progestin “norethisterone” in women with simple endometrial hyperplasia without atypia: A prospective cohort trial
article
OA: diamond
CC0
⤵ 1 in-corpus citation
Abstract
To evaluate the effectiveness of the aromataze inhibitor “letrozole” to progestin “norethisterone” for women with simple endometrial hyperplasia without atypia. One hundred women with a histo-pathological diagnosis of simple endometrial hyperplasia without atypia were divided into two groups: Groups A and B. Group A included 50 patients who received a daily 5 mg dose of letrozole for three successive months. Group B included the other 50 patients who received norethisterone 10 mg daily by non-stop regimen for 3 months. All patients in both groups were reevaluated after treatment. Women diagnosed with progressive or persistent endometrial hyperplasia at the second curettage were asked to continue on the same medication for another 3 months. Transvaginal sonography as well as serum estradiol level measurement were performed before the start of treatment and 3 months after treatment. Despite that there was no statistically significant difference between the two groups as regards the proportion of women whose endometrial sample revealed resolution, regressing or persistence after 3 months of treatment. However, endometrial thickness was significantly thinner in women who received letrazole than in women who received norethisterone (mean difference 0.12 mm, 95% CI: 0.22–0.01, P = 0.02). Serum E2 level was significantly lower in the Group A compared to Group B (mean difference 9.1 pg, 95% CI: 13.74–4.45, P < 0.001). Letrozole is as effective as norethisterone for women with abnormal uterine bleeding due to endometrial hyperplasia without atypia.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- The Effect of Medroxyprogesterone Acetate on Angiogenesis in Complex Endometrial Hyperplasia 1999
- [Long-term observations of the extent and reversibility of bone demineralization after leuprorelin acetate depot therapy]. 1996
Cited by (1)
References (29)
- [Long-term observations of the extent and reversibility of bone demineralization after leuprorelin acetate depot therapy]. via openalex
- The Effect of Medroxyprogesterone Acetate on Angiogenesis in Complex Endometrial Hyperplasia via openalex
- W1979091123 via openalex
- W1981056751 via openalex
- W1987147125 via openalex
- W1992658805 via openalex
- W1994207027 via openalex
- W2000516822 via openalex
- W2005636231 via openalex
- W2006868022 via openalex
- W2012180661 via openalex
- W2037004008 via openalex
- W2039249853 via openalex
- W2044914910 via openalex
- W2046794494 via openalex
- W2057525464 via openalex
- W2064617101 via openalex
- W2073864773 via openalex
- W2080491966 via openalex
- W2145396414 via openalex
- W2157152465 via openalex
- W2397766181 via openalex
- W2409690263 via openalex
- W2473459988 via openalex
- W6661624621 via openalex
- W6714393049 via openalex
- W1968268802 via openalex
- W6716738974 via openalex
- W1970970199 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK